April 18, 2018 / 9:20 AM / 3 months ago

BRIEF-Vicore Pharma Receives Approval To Start Phase IIa Study

April 18 (Reuters) - VICORE PHARMA HOLDING AB:

* VICORE PHARMA RECEIVES APPROVAL TO START PHASE IIA STUDY IN IPF

* APPROVAL FROM BRITISH MEDICINES AGENCY MHRA AND ETHICS COMMITTEE FOR LONDON AND SURREY FOR PHASE IIA STUDY ON IPF Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below